Cargando…
Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic disease that is associated with increased serum levels of markers of systemic inflammation. The triggering receptor expressed on myeloid cells 1 (TREM-1) is a recently identified activating receptor on neutrophils,...
Autores principales: | Radsak, Markus P., Taube, Christian, Haselmayer, Philipp, Tenzer, Stefan, Salih, Helmut R., Wiewrodt, Rainer, Buhl, Roland, Schild, Hansjörg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246041/ https://www.ncbi.nlm.nih.gov/pubmed/18317529 http://dx.doi.org/10.1155/2007/52040 |
Ejemplares similares
-
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
por: Kuemmel, Andreas, et al.
Publicado: (2018) -
Evaluation and Validation of the Detection of soluble Triggering Receptor Expressed on Myeloid Cells 1 by Enzyme-linked immunosorbent Assay
por: Hasibeder, Astrid, et al.
Publicado: (2015) -
A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome
por: Gladigau, Gerd, et al.
Publicado: (2012) -
Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation
por: Stein, Pamela, et al.
Publicado: (2014) -
CD27 expression on Treg cells limits immune responses against tumors
por: Muth, Sabine, et al.
Publicado: (2021)